{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:54:45Z","timestamp":1790456085695,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson\u2019s Research","doi-asserted-by":"publisher","award":["MJFF-10854"],"award-info":[{"award-number":["MJFF-10854"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson\u2019s Research","doi-asserted-by":"publisher","award":["MJFF-010556"],"award-info":[{"award-number":["MJFF-010556"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson\u2019s Research","doi-asserted-by":"publisher","award":["MJFF-025746"],"award-info":[{"award-number":["MJFF-025746"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1K23NS105944-01A1"],"award-info":[{"award-number":["1K23NS105944-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1U19AG071754-01"],"award-info":[{"award-number":["1U19AG071754-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin. Auton. Res."],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>We compared locus coeruleus (LC) structural integrity, as measured by neuromelanin-sensitive magnetic resonance imaging (NM-MRI), between patients with Parkinson\u2019s disease (PD) and those with multiple system atrophy (MSA) and tested whether orthostatic hypotension (OH) impacted differences in LC volume between PD and MSA. Substantia nigra (SNc) volumes were compared between these groups to determine whether effects observed in LC were specific to that structure. Last, we tested whether LC integrity is associated with orthostatic hemodynamic responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Presence or absence of (\u00b1)OH was determined with active stand testing. Automated segmentation of LC and SNc volumes took place using NM-MRI. Structural volumes were first compared between PD and MSA groups and, second, after stratification by OH status. Last, correlations between LC volumes and orthostatic vitals were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 71 patients with PD, 19 were (+)OH. Of 19 patients with MSA, 12 were (+)OH. LC volumes were larger in PD than MSA (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), and LC volumes in PD(\u2212)OH were larger than PD(+)OH and MSA(\u00b1)OH (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). All comparisons involving SNc were nonsignificant. Primarily in PD(\u2212)OH, LC volumes correlated negatively with supine mean arterial pressure (MAP) and positively with supine heart rate. In PD(+OH) and MSA(+)OH, lower LC volumes were correlated with greater orthostatic falls in MAP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Similar levels of LC neurodegeneration were observed in PD(+)OH and MSA(\u00b1)OH. Therefore, LC measurement may be useful to differentiate PD(\u2212)OH from MSA.\u00a0Lower LC volumes additionally correlated with greater drops in MAP in both PD(+)OH and MSA(+)OH, suggesting that\u00a0LC neurodegeneration may contribute to OH in both conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10286-025-01164-2","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:37:51Z","timestamp":1761899871000},"page":"53-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Locus coeruleus degeneration is associated with orthostatic hypotension in Parkinson\u2019s disease and multiple system atrophy"],"prefix":"10.1007","volume":"36","author":[{"given":"Paul A.","family":"Beach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra","family":"Hyland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangchuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0503-3736","authenticated-orcid":false,"given":"Daniel E.","family":"Huddleston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"1164_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB et\u00a0al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 30:1591\u20131601","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1164_CR2","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK et\u00a0al (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37:1131\u20131148","journal-title":"Mov Disord"},{"key":"1164_CR3","doi-asserted-by":"publisher","first-page":"e1168","DOI":"10.1212\/WNL.0000000000200861","volume":"99","author":"E Vichayanrat","year":"2022","unstructured":"Vichayanrat E et\u00a0al (2022) Diagnosing premotor multiple system atrophy: natural history and autonomic testing in an autopsy-confirmed cohort. Neurology 99:e1168\u2013e1177","journal-title":"Neurology"},{"key":"1164_CR4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","volume":"17","author":"DC Velseboer","year":"2011","unstructured":"Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RMA (2011) Prevalence of orthostatic hypotension in Parkinson\u2019s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 17:724\u2013729","journal-title":"Parkinsonism Relat Disord"},{"key":"1164_CR5","doi-asserted-by":"publisher","first-page":"e1526","DOI":"10.1212\/WNL.0000000000008314","volume":"93","author":"YH Hiorth","year":"2019","unstructured":"Hiorth YH, Pedersen KF, Dalen I, Tysnes O-B, Alves G (2019) Orthostatic hypotension in Parkinson disease: a 7-year prospective population-based study. Neurology 93:e1526\u2013e1534","journal-title":"Neurology"},{"key":"1164_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2024.103173","volume":"253","author":"P Beach","year":"2024","unstructured":"Beach P, McKay JL (2024) Longitudinal prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative (PPMI) cohort. Auton Neurosci 253:103173","journal-title":"Auton Neurosci"},{"key":"1164_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.parkreldis.2021.11.002","volume":"93","author":"F Baschieri","year":"2021","unstructured":"Baschieri F et\u00a0al (2021) Neurogenic orthostatic hypotension in early stage Parkinson\u2019s disease: new insights from the first 105 patients of the BoProPark study. Parkinsonism Relat Disord 93:12\u201318","journal-title":"Parkinsonism Relat Disord"},{"key":"1164_CR8","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/brain\/awab017","volume":"144","author":"Y Miki","year":"2021","unstructured":"Miki Y et\u00a0al (2021) Identification of multiple system atrophy mimicking Parkinson\u2019s disease or progressive supranuclear palsy. Brain 144:1138\u20131151","journal-title":"Brain"},{"key":"1164_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","volume":"85","author":"S Koga","year":"2015","unstructured":"Koga S et\u00a0al (2015) When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology 85:404\u2013412","journal-title":"Neurology"},{"key":"1164_CR10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/mds.29304","volume":"38","author":"S Virameteekul","year":"2023","unstructured":"Virameteekul S, Revesz T, Jaunmuktane Z, Warner TT, De Pablo-Fern\u00e1ndez E (2023) Pathological validation of the MDS criteria for the diagnosis of multiple system atrophy. Mov Disord 38:444\u2013452","journal-title":"Mov Disord"},{"key":"1164_CR11","volume":"16","author":"SK Dash","year":"2024","unstructured":"Dash SK et\u00a0al (2024) Imaging markers of multiple system atrophy and their association with disease severity: a cross-sectional study. Cureus 16:e67896","journal-title":"Cureus"},{"key":"1164_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14802\/jmd.18031","volume":"12","author":"C Way","year":"2019","unstructured":"Way C, Pettersson D, Hiller A (2019) The \u2018hot cross bun\u2019 sign is not always multiple system atrophy: etiologies of 11 cases. J Mov Disord 12:27\u201330","journal-title":"J Mov Disord"},{"key":"1164_CR13","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/mdc3.13052","volume":"7","author":"MT Pellecchia","year":"2020","unstructured":"Pellecchia MT et\u00a0al (2020) Can autonomic testing and imaging contribute to the early diagnosis of multiple system atrophy? A systematic review and recommendations by the Movement Disorder Society Multiple System Atrophy Study Group. Mov Disord Clin Pract 7:750\u2013762","journal-title":"Mov Disord Clin Pract"},{"key":"1164_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neuroimage.2005.12.006","volume":"31","author":"K Seppi","year":"2006","unstructured":"Seppi K et\u00a0al (2006) Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage 31:240\u2013245","journal-title":"Neuroimage"},{"key":"1164_CR15","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/brain\/aws055","volume":"135","author":"DS Goldstein","year":"2012","unstructured":"Goldstein DS, Holmes C, Sharabi Y (2012) Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson\u2019s disease and other synucleinopathies. Brain J Neurol 135:1900\u20131913","journal-title":"Brain J Neurol"},{"key":"1164_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/brain\/awad300","volume":"147","author":"P Trujillo","year":"2024","unstructured":"Trujillo P, Aumann MA, Claassen DO (2024) Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function. Brain 147:337\u2013351","journal-title":"Brain"},{"key":"1164_CR17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00234-013-1199-9","volume":"55","author":"S Kitao","year":"2013","unstructured":"Kitao S et\u00a0al (2013) Correlation between pathology and neuromelanin MR imaging in Parkinson\u2019s disease and dementia with Lewy bodies. Neuroradiology 55:947\u2013953","journal-title":"Neuroradiology"},{"key":"1164_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroimage.2015.03.020","volume":"113","author":"NI Keren","year":"2015","unstructured":"Keren NI et\u00a0al (2015) Histologic validation of locus coeruleus MRI contrast in post-mortem tissue. Neuroimage 113:235\u2013245","journal-title":"Neuroimage"},{"key":"1164_CR19","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1073\/pnas.1807983116","volume":"116","author":"CM Cassidy","year":"2019","unstructured":"Cassidy CM et\u00a0al (2019) Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc Natl Acad Sci U S A 116:5108\u20135117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1164_CR20","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/mds.28988","volume":"37","author":"L Chougar","year":"2022","unstructured":"Chougar L et\u00a0al (2022) Regional selectivity of neuromelanin changes in the substantia nigra in atypical parkinsonism. Mov Disord 37:1245\u20131255","journal-title":"Mov Disord"},{"key":"1164_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neulet.2013.02.012","volume":"541","author":"C Ohtsuka","year":"2013","unstructured":"Ohtsuka C et\u00a0al (2013) Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson\u2019s disease using neuromelanin-sensitive MR imaging. Neurosci Lett 541:93\u201398","journal-title":"Neurosci Lett"},{"key":"1164_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282684","volume":"18","author":"KS Hwang","year":"2023","unstructured":"Hwang KS, Langley J, Tripathi R, Hu XP, Huddleston DE (2023) In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson\u2019s disease using neuromelanin-sensitive MRI: replication in two cohorts. PLoS ONE 18:e0282684","journal-title":"PLoS ONE"},{"key":"1164_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000350291","volume":"70","author":"K Matsuura","year":"2013","unstructured":"Matsuura K et\u00a0al (2013) Neuromelanin magnetic resonance imaging in Parkinson\u2019s disease and multiple system atrophy. Eur Neurol 70:70\u201377","journal-title":"Eur Neurol"},{"key":"1164_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/mds.29309","volume":"38","author":"A Nobileau","year":"2023","unstructured":"Nobileau A et\u00a0al (2023) Neuromelanin-sensitive magnetic resonance imaging changes in the locus coeruleus\/subcoeruleus complex in patients with typical and atypical parkinsonism. Mov Disord 38:479\u2013484","journal-title":"Mov Disord"},{"key":"1164_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1566-0702(01)00374-5","volume":"96","author":"EE Benarroch","year":"2002","unstructured":"Benarroch EE (2002) New findings on the neuropathology of multiple system atrophy. Auton Neurosci 96:59\u201362","journal-title":"Auton Neurosci"},{"key":"1164_CR26","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1111\/jnc.16168","volume":"168","author":"DS Goldstein","year":"2024","unstructured":"Goldstein DS, Sullivan P, Holmes C (2024) Cerebrospinal fluid concentration gradients of catechols in synucleinopathies. J Neurochem 168:2926\u20132934","journal-title":"J Neurochem"},{"key":"1164_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.parkreldis.2014.04.005","volume":"20","author":"C Ohtsuka","year":"2014","unstructured":"Ohtsuka C et\u00a0al (2014) Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat Disord 20:755\u2013760","journal-title":"Parkinsonism Relat Disord"},{"key":"1164_CR28","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2169\/internalmedicine.50.5101","volume":"50","author":"K Kashihara","year":"2011","unstructured":"Kashihara K, Shinya T, Higaki F (2011) Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med Tokyo Jpn 50:1683\u20131687","journal-title":"Intern Med Tokyo Jpn"},{"key":"1164_CR29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12883-020-02007-5","volume":"20","author":"RM Sim\u00f5es","year":"2020","unstructured":"Sim\u00f5es RM et\u00a0al (2020) A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy. BMC Neurol 20:432","journal-title":"BMC Neurol"},{"key":"1164_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.parkreldis.2021.05.002","volume":"87","author":"K Matsuura","year":"2021","unstructured":"Matsuura K et\u00a0al (2021) Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia. Parkinsonism Relat Disord 87:75\u201381","journal-title":"Parkinsonism Relat Disord"},{"key":"1164_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10286-015-0271-4","volume":"25","author":"J Jordan","year":"2015","unstructured":"Jordan J, Shibao C, Biaggioni I (2015) Multiple system atrophy. Using clinical pharmacology to reveal pathophysiology. Clin Auton Res 25:53\u201359","journal-title":"Clin Auton Res"},{"key":"1164_CR32","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nbd.2011.10.025","volume":"46","author":"S Jain","year":"2012","unstructured":"Jain S, Goldstein DS (2012) Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis 46:572\u2013580","journal-title":"Neurobiol Dis"},{"key":"1164_CR33","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","volume":"72","author":"S-M Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad S-M et\u00a0al (2015) New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 72:863\u2013873","journal-title":"JAMA Neurol"},{"key":"1164_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106101","volume":"122","author":"J Horsager","year":"2024","unstructured":"Horsager J, Borghammer P (2024) Brain-first vs. body-first Parkinson\u2019s disease: an update on recent evidence. Parkinsonism Relat Disord 122:106101","journal-title":"Parkinsonism Relat Disord"},{"key":"1164_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/mds.28945","volume":"37","author":"CF Madelung","year":"2022","unstructured":"Madelung CF et\u00a0al (2022) Locus coeruleus shows a spatial pattern of structural disintegration in Parkinson\u2019s disease. Mov Disord 37:479\u2013489","journal-title":"Mov Disord"},{"key":"1164_CR36","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/brain\/awx348","volume":"141","author":"M Sommerauer","year":"2018","unstructured":"Sommerauer M et\u00a0al (2018) Evaluation of the noradrenergic system in Parkinson\u2019s disease: an 11C-MeNER PET and neuromelanin MRI study. Brain J Neurol 141:496\u2013504","journal-title":"Brain J Neurol"},{"key":"1164_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1164_CR38","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S et\u00a0al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676","journal-title":"Neurology"},{"key":"1164_CR39","volume-title":"The unified Parkinson\u2019s disease rating scale recent developments in Parkinson\u2019s disease","author":"S Fahn","year":"1987","unstructured":"Fahn S, Elton R, Members of the UPDRS Development Committee (1987) The unified Parkinson\u2019s disease rating scale recent developments in Parkinson\u2019s disease. Macmillan Health Care Information, Florham Park, NJ"},{"key":"1164_CR40","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS et\u00a0al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699","journal-title":"J Am Geriatr Soc"},{"key":"1164_CR41","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.20153","volume":"19","author":"M Visser","year":"2004","unstructured":"Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson\u2019s disease: the SCOPA-AUT. Mov Disord Off J Mov Disord Soc 19:1306\u20131312","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1164_CR42","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.21740","volume":"22","author":"K Stiasny-Kolster","year":"2007","unstructured":"Stiasny-Kolster K et\u00a0al (2007) The REM sleep behavior disorder screening questionnaire\u2014A new diagnostic instrument. Mov Disord Off J Mov Disord Soc 22:2386\u20132393","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1164_CR43","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.sleep.2011.01.015","volume":"12","author":"T Nomura","year":"2011","unstructured":"Nomura T, Inoue Y, Kagimura T, Uemura Y, Nakashima K (2011) Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson\u2019s disease patients. Sleep Med 12:711\u2013713","journal-title":"Sleep Med"},{"key":"1164_CR44","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3389\/fneur.2020.00897","volume":"11","author":"K Longardner","year":"2020","unstructured":"Longardner K, Bayram E, Litvan I (2020) Orthostatic hypotension is associated with cognitive decline in Parkinson disease. Front Neurol 11:897","journal-title":"Front Neurol"},{"key":"1164_CR45","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1212\/WNL.46.5.1470","volume":"46","author":"Consensus Committee of the American Autonomic Society and the American Academy of Neurology","year":"1996","unstructured":"Consensus Committee of the American Autonomic Society and the American Academy of Neurology (1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 46:1470","journal-title":"Neurology"},{"key":"1164_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1212\/01.wnl.0000223828.28215.0b","volume":"67","author":"CH Gibbons","year":"2006","unstructured":"Gibbons CH, Freeman R (2006) Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology 67:28\u201332","journal-title":"Neurology"},{"key":"1164_CR47","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.25170","volume":"83","author":"L Norcliffe-Kaufmann","year":"2018","unstructured":"Norcliffe-Kaufmann L et\u00a0al (2018) Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol 83:522\u2013531","journal-title":"Ann Neurol"},{"key":"1164_CR48","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ana.25834","volume":"88","author":"A Fanciulli","year":"2020","unstructured":"Fanciulli A et\u00a0al (2020) Validation of the neurogenic orthostatic hypotension ratio with active standing. Ann Neurol 88:643\u2013645","journal-title":"Ann Neurol"},{"key":"1164_CR49","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","volume":"23","author":"SM Smith","year":"2004","unstructured":"Smith SM et\u00a0al (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23:S208\u2013S219","journal-title":"Neuroimage"},{"key":"1164_CR50","doi-asserted-by":"crossref","unstructured":"Cox RW, Hyde JS (1996) AFNI and SUMA: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29(3):162\u2013173. Available at: https:\/\/afni.nimh.nih.gov","DOI":"10.1006\/cbmr.1996.0014"},{"key":"1164_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","volume":"5","author":"M Jenkinson","year":"2001","unstructured":"Jenkinson M, Smith S (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5:143\u2013156","journal-title":"Med Image Anal"},{"key":"1164_CR52","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1006\/nimg.2002.1132","volume":"17","author":"M Jenkinson","year":"2002","unstructured":"Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17:825\u2013841","journal-title":"Neuroimage"},{"key":"1164_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.parkreldis.2020.09.021","volume":"80","author":"J Langley","year":"2020","unstructured":"Langley J et\u00a0al (2020) Multimodal assessment of nigrosomal degeneration in Parkinson\u2019s disease. Parkinsonism Relat Disord 80:102\u2013107","journal-title":"Parkinsonism Relat Disord"},{"key":"1164_CR54","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10334-016-0590-z","volume":"30","author":"J Langley","year":"2017","unstructured":"Langley J, Huddleston DE, Liu CJ, Hu X (2017) Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI. Magn Reson Mater Phys Biol Med 30:121\u2013125","journal-title":"Magn Reson Mater Phys Biol Med"},{"key":"1164_CR55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neurobiolaging.2019.11.016","volume":"87","author":"J Langley","year":"2020","unstructured":"Langley J, Hussain S, Flores JJ, Bennett IJ, Hu X (2020) Characterization of age-related microstructural changes in locus coeruleus and substantia nigra pars compacta. Neurobiol Aging 87:89\u201397","journal-title":"Neurobiol Aging"},{"key":"1164_CR56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/157015908785777229","volume":"6","author":"ER Samuels","year":"2008","unstructured":"Samuels ER, Szabadi E (2008) Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr Neuropharmacol 6:235\u2013253","journal-title":"Curr Neuropharmacol"},{"key":"1164_CR57","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jmri.27384","volume":"53","author":"M van der Pluijm","year":"2021","unstructured":"van der Pluijm M et\u00a0al (2021) Reliability and reproducibility of neuromelanin-sensitive imaging of the Substantia Nigra: a comparison of three different sequences. J Magn Reson Imaging 53:712\u2013721","journal-title":"J Magn Reson Imaging"},{"key":"1164_CR58","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/mds.26989","volume":"32","author":"S-M Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad S-M et\u00a0al (2017) Validation of the MDS research criteria for prodromal Parkinson\u2019s disease: longitudinal assessment in a REM sleep behavior disorder (RBD) cohort. Mov Disord 32:865\u2013873","journal-title":"Mov Disord"},{"key":"1164_CR59","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1136\/jnnp-2019-320846","volume":"90","author":"A Pilotto","year":"2019","unstructured":"Pilotto A et\u00a0al (2019) Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in \u03b1-synucleinopathies. J Neurol Neurosurg Psychiatry 90:1257\u20131263","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1164_CR60","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1007\/s00415-022-11221-9","volume":"269","author":"K Longardner","year":"2022","unstructured":"Longardner K et\u00a0al (2022) Differential impact of individual autonomic domains on clinical outcomes in Parkinson\u2019s disease. J Neurol 269:5510\u20135520","journal-title":"J Neurol"},{"key":"1164_CR61","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0361-9230(99)00183-5","volume":"50","author":"JA Anselmo-Franci","year":"1999","unstructured":"Anselmo-Franci JA et\u00a0al (1999) Role of the locus coeruleus on blood pressure response and atrial natriuretic peptide secretion following extracellular volume expansion. Brain Res Bull 50:173\u2013177","journal-title":"Brain Res Bull"},{"key":"1164_CR62","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2174\/157015908785777193","volume":"6","author":"ER Samuels","year":"2008","unstructured":"Samuels ER, Szabadi ER (2008) Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr Neuropharmacol 6:254\u2013285","journal-title":"Curr Neuropharmacol"},{"key":"1164_CR63","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.5093-13.2014","volume":"34","author":"X Wang","year":"2014","unstructured":"Wang X, Pi\u00f1ol RA, Byrne P, Mendelowitz D (2014) Optogenetic stimulation of locus ceruleus neurons augments inhibitory transmission to parasympathetic cardiac vagal neurons via activation of brainstem \u03b11 and \u03b21 receptors. J Neurosci 34:6182\u20136189","journal-title":"J Neurosci"},{"key":"1164_CR64","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0006-8993(91)90435-X","volume":"538","author":"FM Clark","year":"1991","unstructured":"Clark FM, Proudfit HK (1991) The projection of locus coeruleus neurons to the spinal cord in the rat determined by anterograde tracing combined with immunocytochemistry. Brain Res 538:231\u2013245","journal-title":"Brain Res"},{"key":"1164_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.autneu.2012.12.008","volume":"175","author":"RAL Dampney","year":"2013","unstructured":"Dampney RAL, Furlong TM, Horiuchi J, Iigaya K (2013) Role of dorsolateral periaqueductal grey in the coordinated regulation of cardiovascular and respiratory function. Auton Neurosci 175:17\u201325","journal-title":"Auton Neurosci"},{"key":"1164_CR66","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0306-4522(94)90439-1","volume":"61","author":"Y-W Li","year":"1994","unstructured":"Li Y-W, Dampney RAL (1994) Expression of fos-like protein in brain following sustained hypertension and hypotension in conscious rabbits. Neuroscience 61:613\u2013634","journal-title":"Neuroscience"},{"key":"1164_CR67","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0306-4522(94)90440-5","volume":"61","author":"S Murase","year":"1994","unstructured":"Murase S, Inui K, Nosaka S (1994) Baroreceptor inhibition of the locus coeruleus noradrenergic neurons. Neuroscience 61:635\u2013643","journal-title":"Neuroscience"},{"key":"1164_CR68","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0165-0173(82)90010-8","volume":"4","author":"PE Sawchenko","year":"1982","unstructured":"Sawchenko PE, Swanson LW (1982) The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res Rev 4:275\u2013325","journal-title":"Brain Res Rev"},{"key":"1164_CR69","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0024-3205(91)90172-8","volume":"49","author":"H Geiger","year":"1991","unstructured":"Geiger H, Bahner U, Palkovits M, Heidland A, Sterzel RB (1991) Atrial natriuretic peptide in the locus coeruleus and its possible role in the regulation of arterial blood pressure, fluid and electrolyte homeostasis. Life Sci 49:869\u2013879","journal-title":"Life Sci"},{"key":"1164_CR70","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1159\/000520192","volume":"112","author":"KV Thrivikraman","year":"2022","unstructured":"Thrivikraman KV, Kinkead B, Owens MJ, Rapaport MH, Plotsky PM (2022) Locus coeruleus noradrenergic modulation of diurnal corticosterone, stress reactivity and cardiovascular homeostasis in male rats. Neuroendocrinology 112:763\u2013776","journal-title":"Neuroendocrinology"},{"key":"1164_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1570161043476483","volume":"2","author":"S Yang","year":"2004","unstructured":"Yang S, Zhang L (2004) Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2:1\u201312","journal-title":"Curr Vasc Pharmacol"},{"key":"1164_CR72","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00702-023-02721-7","volume":"131","author":"G Palermo","year":"2024","unstructured":"Palermo G et\u00a0al (2024) Neurogenic orthostatic hypotension in Parkinson\u2019s disease: is there a role for locus coeruleus magnetic resonance imaging? J Neural Transm 131:157\u2013164","journal-title":"J Neural Transm"},{"key":"1164_CR73","first-page":"233","volume":"11","author":"Q Tong","year":"2021","unstructured":"Tong Q, Chen L (2021) Lack of association of locus coeruleus pathology with orthostatic hypotension in Parkinson\u2019s disease. J Park Dis 11:233\u2013237","journal-title":"J Park Dis"},{"key":"1164_CR74","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.nbd.2011.12.053","volume":"46","author":"SJ Lewis","year":"2012","unstructured":"Lewis SJ et\u00a0al (2012) Brain monoamine systems in multiple system atrophy: a positron emission tomography study. Neurobiol Dis 46:130\u2013136","journal-title":"Neurobiol Dis"},{"key":"1164_CR75","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neuropharm.2013.08.033","volume":"76","author":"TN Taylor","year":"2014","unstructured":"Taylor TN, Alter SP, Wang M, Goldstein DS, Miller GW (2014) Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus. Neuropharmacology 76:97\u2013105","journal-title":"Neuropharmacology"},{"key":"1164_CR76","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41582-023-00802-5","volume":"19","author":"K Ray Chaudhuri","year":"2023","unstructured":"Ray Chaudhuri K, Leta V, Bannister K, Brooks DJ, Svenningsson P (2023) The noradrenergic subtype of Parkinson disease: from animal models to clinical practice. Nat Rev Neurol 19:333\u2013345","journal-title":"Nat Rev Neurol"},{"key":"1164_CR77","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1212\/WNL.0000000000003426","volume":"87","author":"N Pyatigorskaya","year":"2016","unstructured":"Pyatigorskaya N et\u00a0al (2016) Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease. Neurology 87:2540\u20132545","journal-title":"Neurology"},{"key":"1164_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00371","author":"K Janitzky","year":"2020","unstructured":"Janitzky K (2020) Impaired phasic discharge of locus coeruleus neurons based on persistent high tonic discharge\u2014A new hypothesis with potential implications for neurodegenerative diseases. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2020.00371","journal-title":"Front Neurol"},{"issue":"Suppl 1","key":"1164_CR79","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.3949\/ccjm.74.Suppl_1.S91","volume":"74","author":"DS Goldstein","year":"2007","unstructured":"Goldstein DS (2007) Cardiac denervation in patients with Parkinson disease. Cleve Clin J Med 74(Suppl 1):S91-94","journal-title":"Cleve Clin J Med"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-025-01164-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10286-025-01164-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-025-01164-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:02:58Z","timestamp":1773309778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10286-025-01164-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1164"],"URL":"https:\/\/doi.org\/10.1007\/s10286-025-01164-2","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}